Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 4 1Phase 1/2 1

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 15Genitourinary 9Head & Neck 5Gastrointestinal 5Thoracic 4Other 4Lymphoid 4Plasma cell 3Gynecologic 3Dermatologic 3Other hematologic neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Myeloid 1CNS 1

Conditions

Head and Neck Neoplasms 4cyclopia sequence 2Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Laryngeal Diseases 1Fatigue 1Depressive Disorder, Major 1Depression 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Sugars × Head & Neck × Clear all
NCT01330446 2024-02-14

Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Head & Neck

Fatigue, Head and Neck Neoplasms

NCT00536172 2023-09-21

PROTECT

University of Nebraska

Phase 4 Completed
160 enrolled 15 charts
Head & Neck

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT02055963 2022-10-20

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
30 enrolled 9 charts
Head & Neck

cyclopia sequence, Head and Neck Neoplasms

NCT01173692 2021-08-20

Minocycline for Reduction of Radiation Therapy Treatment-Related Symptom Burden in Oropharynx Cancer: A Randomized Study.

M.D. Anderson Cancer Center

Phase 2 Completed
47 enrolled 7 charts
Head & Neck

cyclopia sequence, Oropharyngeal Neoplasms

NCT01427205 2013-04-05

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡